| name | es-cushing-re-evaluate-pituitary-hormone-deficiencies-postop |
| description | This skill recommends re-evaluating the need for treatment of other pituitary hormone deficiencies in the postoperative period following surgical intervention for Cushing's syndrome. It is triggered when assessing a post-op CS patient for ongoing pituitary function, evaluating for hypopituitarism, or checking HPA axis recovery with morning cortisol/ACTH stimulation tests and pituitary MRI within 1–3 months. |
Re-Evaluating Need for Treatment of Other Pituitary Hormone Deficiencies in Postoperative Period
STEP 1 — Gather Information
Collect postoperative clinical data (symptoms of fatigue, weight loss, hypotension, cold intolerance, loss of libido, etc.) and laboratory studies: morning serum cortisol, ACTH stimulation test or insulin-induced hypoglycemia test, free T4, TSH, prolactin, LH/FSH, estradiol/testosterone, IGF-1, and serum sodium; obtain postoperative pituitary MRI within 1–3 months if transsphenoidal surgery performed.
STEP 2 — Rule In / Rule Out
Determine whether there is biochemical evidence of pituitary hormone deficiency (e.g., low morning cortisol with subnormal ACTH response, low free T4 with inappropriately normal/low TSH, low prolactin, low LH/FSH with low sex steroids, low IGF-1) versus normal function.
STEP 3 — Classify or Stratify
Classify which pituitary axes are deficient (ACTH, thyroid, gonadal, growth hormone) and assess severity (mild, moderate, severe) based on hormone levels and clinical symptoms.
STEP 4 — Decide
Initiate appropriate hormone replacement for each deficient axis (glucocorticoid, levothyroxine, sex steroids, GH if indicated), provide patient education on adrenal insufficiency and stress dosing, and schedule follow‑up testing to assess for potential recovery of axis function.
Clinical Guardrails / Mimics / Pitfalls
Do not discontinue glucocorticoid replacement without confirming HPA axis recovery; avoid overlooking central hypothyroidism or hypogonadism because symptoms may be subtle; do not assume all deficiencies are permanent—re‑evaluate periodically; avoid giving estrogen/testosterone without confirming gonadal axis deficiency; be cautious of precipitating adrenal crisis during illness if glucocorticoid replacement is inadequate.
Concrete Clinical Example
A 48‑year‑old woman undergoes transsphenoidal resection of an ACTH‑secreting pituitary macroadenoma for Cushing's disease. On postoperative day 7 she reports fatigue and dizziness. Labs show morning cortisol 3 µg/dL (low), subnormal response to ACTH stimulation, free T4 0.6 ng/dL with TSH 2 µIU/mL (inappropriately normal), prolactin <2 ng/mL, IGF‑1 80 ng/mL (low). She is started on hydrocortisone 15 mg/day divided, levothyroxine 75 µg/day, and referred for endocrine follow‑up; testosterone replacement is deferred until gonadal axis is further assessed.
Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818
